Odyssey Thera
Pioneering cellular pharmacology to discover groundbreaking cancer therapies.
Pioneering cellular pharmacology to discover groundbreaking cancer therapies.
Odyssey Thera is a biopharmaceutical company focused on utilizing cellular pharmacology strategies to identify groundbreaking therapies for cancer. Established in 2000, in San Ramon, California, the company has undergone significant growth, attracting a substantial $2.80M in Venture Round investment on 14 February 2013, from notable investors including Burrill & Company, HBM Partners, and Lonza. Specializing in Biopharma, Biotechnology, Health Care, and Pharmaceutical industries, Odyssey Thera, Inc. is committed to developing treatment therapies for cancer, demonstrating a strong potential for both social impact and investment returns.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $2.80M | 3 |
|
14 Feb 2013 |
| Venture Round | $3.50M | - | 17 Mar 2010 |
No recent news or press coverage available for Odyssey Thera.
We care about your data, and we'd love to use cookies make your experience better.
